TrialFind
Saved trials
Back to results
Completed
Phase 2
Efficacy and Safety of Escitalopram for Prevention of Depression Induced by Peg-Interferon in Hepatitis C Patients
NCT00166296
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Fundacion Hospital Alcorcon
Alcorcón, Spain
+14 additional locations
View on ClinicalTrials.gov
Official details
Efficacy and Safety of Escitalopram for Prevention of Depression Induced by Peg-Interferon in Hepatitis C Patients — TrialFind